Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

10.83 -0.22 (-1.99%)
Streaming Delayed Price Updated: 3:25 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,520,027
Open 11.17
Bid (Size) 10.83 (200)
Ask (Size) 10.84 (600)
Prev. Close 11.05
Today's Range 10.81 - 11.26
52wk Range 9.200 - 14.63
Shares Outstanding 128,489,060
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study ↗
Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025. 
Via Benzinga
News headline image
Dynavax (DVAX) Q2 Revenue Jumps 29% ↗
Via The Motley Fool

Performance

YTD
-16.0%
-16.0%
1 Month
+7.6%
+7.6%
3 Month
+3.9%
+3.9%
6 Month
+9.4%
+9.4%
1 Year
-9.8%
-9.8%

More News

Read More
News headline image
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
From Deep Track Capital, LP
Via Business Wire
News headline image
Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
From Deep Track Capital, LP
Via Business Wire
News headline image
Earnings Scheduled For May 6, 2025 ↗
Via Benzinga
News headline image
Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings) ↗
Via Benzinga
News headline image
Earnings Scheduled For February 20, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' ↗
Via Benzinga
News headline image
Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel' ↗
Via Benzinga
Topics Government
News headline image
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗
Via Benzinga
Dynavax’s Experimental Shingles Vaccine Shows Positive Results In Study: Retail Expects Stock Rally To Continue Into Friday ↗
Via Stocktwits
News headline image
Earnings Scheduled For August 7, 2025 ↗
Via Benzinga
News headline image
Deep Track Capital Comments on ISS Recommendation
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting
From Deep Track Capital, LP
Via Business Wire
News headline image
Breaking Down Dynavax Technologies: 5 Analysts Share Their Views ↗
Via Benzinga
News headline image
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗
Via Benzinga
News headline image
Deep Track Capital Releases Investor Presentation on Dynavax Technologies
From Deep Track Capital, LP
Via Business Wire
News headline image
Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders
From Deep Track Capital, LP
Via Business Wire
News headline image
Where Dynavax Technologies Stands With Analysts ↗
Via Benzinga
News headline image
Deep Track Capital Comments on Dynavax Technologies’ Rejection of Most Recent Settlement Offer
From Deep Track Capital, LP
Via Business Wire
News headline image
Evaluating DYNAVAX TECHNOLOGIES CORP (NASDAQ:DVAX) using Mark Minervini’s winning stock formula ↗
Via Chartmill
News headline image
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
From Deep Track Capital, LP
Via Business Wire
News headline image
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
From Deep Track Capital, LP
Via Business Wire

Frequently Asked Questions

Is Dynavax Technologies Corporation - Common Stock publicly traded?
Yes, Dynavax Technologies Corporation - Common Stock is publicly traded.
What exchange does Dynavax Technologies Corporation - Common Stock trade on?
Dynavax Technologies Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dynavax Technologies Corporation - Common Stock?
The ticker symbol for Dynavax Technologies Corporation - Common Stock is DVAX on the Nasdaq Stock Market
What is the current price of Dynavax Technologies Corporation - Common Stock?
The current price of Dynavax Technologies Corporation - Common Stock is 10.83
When was Dynavax Technologies Corporation - Common Stock last traded?
The last trade of Dynavax Technologies Corporation - Common Stock was at 11/20/25 03:25 PM ET
What is the market capitalization of Dynavax Technologies Corporation - Common Stock?
The market capitalization of Dynavax Technologies Corporation - Common Stock is 1.39B
How many shares of Dynavax Technologies Corporation - Common Stock are outstanding?
Dynavax Technologies Corporation - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.